The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Hospitals

Stanford's AI Discharge Tool Eases Physician Burnout

Stanford Health Care piloted an in-house AI agent that writes hospital discharge summaries and found it reduced physician burnout, according to Becker's Hospital Review. Researchers at Stanford Medicine built the tool, called MedAgentBrief, and deployed it at Sequoia Hospital in Redwood City, California.

Over 10 weeks, 11 hospitalist physicians received AI-generated discharge summaries for each of their patients. Discharge summaries are time-consuming to write and are a frequent source of after-hours documentation work, the kind of administrative load repeatedly tied to clinician burnout.

The pilot reflects where hospital AI adoption is heading. Health systems are concentrating early generative AI deployments on documentation and administrative tasks, where the technology can save time with lower clinical risk than diagnostic or treatment decisions. Building the tool in-house also gives Stanford more control over how patient data is handled and how the model behaves. The next test for tools like MedAgentBrief is whether burnout gains hold at scale and whether the generated summaries meet accuracy and safety standards across larger patient populations.

More in Hospitals

Hospitals

Visitor Fatally Shot at HCA Missouri Hospital; Patient Charged

A visitor was fatally shot at HCA Healthcare's Centerpoint Medical Center in Missouri, and patient James Lawson faces second-degree murder charges.

Why it matters: Violence inside hospitals is driving systems to rethink weapons screening and access control to protect patients, staff, and visitors.

Hospitals

Pay Dispute Puts Illinois Hospital's Trauma Status at Risk

An Illinois hospital's level 2 trauma designation is under state review after its anesthesia group suspended services over a missed payment.

Why it matters: A single vendor contract breakdown can strip a hospital of its trauma status and leave a community without nearby emergency surgical care.

Hospitals

Merck-Moderna mRNA Cancer Vaccine Cuts Melanoma Risk 42%

Merck and Moderna's personalized mRNA cancer vaccine cut melanoma recurrence or death by 42% in a phase 3 trial when paired with Keytruda immunotherapy.

Why it matters: A successful phase 3 readout signals that personalized mRNA cancer vaccines are nearing clinical reality for high-risk cancer patients.